SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-22-010875
Filing Date
2022-03-17
Accepted
2022-03-17 16:28:37
Documents
79
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K trvi-10k_20211231.htm   iXBRL 10-K 3292926
2 EX-23.1 trvi-ex231_10.htm EX-23.1 8241
3 EX-31.1 trvi-ex311_9.htm EX-31.1 17197
4 EX-31.2 trvi-ex312_6.htm EX-31.2 18630
5 EX-32.1 trvi-ex321_7.htm EX-32.1 11644
6 EX-32.2 trvi-ex322_8.htm EX-32.2 11439
7 GRAPHIC g0hmxnov31nd000001.jpg GRAPHIC 92674
8 GRAPHIC g0hmxnov31nd000003.jpg GRAPHIC 22533
9 GRAPHIC g0hmxnov31nd000002.jpg GRAPHIC 49647
  Complete submission text file 0001564590-22-010875.txt   10601554

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA trvi-20211231.xsd EX-101.SCH 63622
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE trvi-20211231_cal.xml EX-101.CAL 55804
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE trvi-20211231_def.xml EX-101.DEF 203554
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE trvi-20211231_lab.xml EX-101.LAB 498604
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE trvi-20211231_pre.xml EX-101.PRE 387304
73 EXTRACTED XBRL INSTANCE DOCUMENT trvi-10k_20211231_htm.xml XML 1672562
Mailing Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Filer) CIK: 0001563880 (see all company filings)

IRS No.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38886 | Film No.: 22748923
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences